ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Paul Tempst

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6680-3987; OpenAlex author ID A5009347072; NIH RePORTER profile ID 2156915. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 grant

Papers 1

Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges. Co-author DOI 10.3390/cancers10030067 ↗

Grants 1

Protein and proteolytic activity biomarkers of early stage pancreatic cancer R01CA208401 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kenneth H. Yu · 1 shared paper, 1 shared grant, 2018–2021 · strength 0.68
- Grant Protein and proteolytic activity biomarkers of early stage pancreatic cancer R01CA208401 ↗
- Paper Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges. DOI 10.3390/cancers10030067 ↗
Alex Root · 1 shared paper, 2018 · strength 0.12
- Paper Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges. DOI 10.3390/cancers10030067 ↗
Peter J. Allen · 1 shared paper, 2018 · strength 0.12
- Paper Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges. DOI 10.3390/cancers10030067 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.